Our daily digest of news from UK Small Caps
* A corporate client of Hybridan LLP.
** Potential means Intention to Float (ITF) or similar announcement has been made.
***Arranged by type of listing and date of announcement.
****Alphabetically arranged and priced on Share Price and Market Capitalisation during the time of writing on the day of Publication.
Dish of the Day
Admissions:
None
Delistings:
None
What’s baking in the oven?
Market Movers:***
14 January: GlobalData (DATA.L), the data, insight, and technology Company expects to submit its application to move to the Main Market from AIM and to take place on 5 March.
Banquet Buffet****
Acuity RM Group 0.95p £2.22m (ACRM.L)
The software group specialising in cyber-security, which supplies its award-winning STREAM software platform for the Governance, Risk and Compliance market has announced that it has won a new contract. The end user is a new part of a long-standing customer. The three year contract with the British Government has a total value of £178,497. The value in the first year is £70,499. comprising licences and services, with licence fees in the following years.
Agronomics Limited 5.90p £61.92m (ANIC.L)
The clean food investment Company reports interim results to December 2025 of a record net profit of £10.01m compared to a £6.56m loss driven by an investment gain of £10.71m. The Operating expenses were £0.70m against £0.68m. The Net Asset Value per Share increased 11.7% to 13.78p which at a share price of 6.2p at the full year end is a discount of 55%. The cash and cash equivalents and bank deposits are £2.15m, down from £3.61m. The investment strategy is to continue to invest in companies developing technologies that can materially improve the way food and food ingredients are produced, with a clear focus on scalability, capital discipline, and defensible intellectual property. In 2026 several of the portfolio companies are expected to move from development into commercial execution.
Defence Holdings 1.25p £32.76m (ALRT.L)
The UK’s listed software-led defence technology Company today announced the launch of the Defence Holdings Accelerator, a structured programme designed to identify, harden and deploy early-stage sovereign software capabilities into UK and allied defence environments. In parallel, the Company provides an operational update on Project Ixian, with the project progress in line with expectations. Activity is advancing through established UK Defence technical, security and commercial protocols consistent with delivery within classified operational environments.
Feedback 10.60p £4.64m (FDBK.L)
The clinical infrastructure specialists announced its interims to November 2025. Revenue is slightly lower at £0.41m compared to £0.45m, of which Bleepa contributed 89%. The EBITDA loss increased to £1.61m from £1.43m, driven by new support team hires to deliver customer roll outs and technology costs associated with delivering the cloud solution. Cash of £3.82m is down from £5.95m since May 2025. There is increasing dialogue with larger partners to the NHS around deploying Bleepa in their offerings. The NHS 10 Year Plan and its stated direction of travel are closely aligned with the solutions provided by Feedback Medical. The funding committed through the NHS Spending Review is expected to flow to frontline services for the upcoming 2026/27 NHS year and this has the potential to support a new phase of commercial progress.
Haydale 0.42p £31.88m (HAYD.L)
The advanced materials and clean-technology Company announces its audited results for the 15-month period ended 30 September 2025. FY25 reflects the deliberate wind-down of legacy overseas operations. The post-period acquisition of SMCC and subsequent commercial acceleration mark a structural inflection in revenue visibility, execution capacity and route-to-market strength. Revenue was 2.51m and the gross margin was 57%, alongside an adjusted operating loss of 4.02m.
MTI Wireless Edge Ltd 60.50p £44.39m (MWE.L)
The technology Company focused on comprehensive communication and radio frequency solutions across multiple sectors provides an unaudited trading update for the year ended 31 December 2025. MTI expects to report FY2025 revenues of approximately $51.5m, which is at the high end of the range of current market expectations. Following very strong growth in EBIT in FY2025 (approximately 30% over 2024), the Company expects reported FY2025 earnings per share to be significantly ahead of current market expectations. The Company expects net cash at the end of FY2025 to be approximately $9.4m, being significantly ahead of current market expectations. MTI expects to announce its audited final results for FY2025 in early March 2026.
Oracle Power 0.06p £8.65m (ORCP.L)
The international project developer announced that all objections to its application for a Mining Lease (M25/389) covering the Northern Zone gold project have been settled and the Company is now working with its lawyers to have the Mining Lease recommended for approval and granted by Department of Mines, Petroleum and Exploration as soon as possible. The Northern Zone Intrusive Hosted Gold Project is located within the Company's Kalgoorlie Gold Project just 25km east of Kalgoorlie in Western Australia.
Rockfire Resources 0.1925p £17m (ROCK.L)
The base metal, critical mineral and precious metal exploration Company, provided a drilling update from Rockfire's 100%-owned Molaoi zinc deposit in Greece. The Company continues diamond drilling to upgrade the Inferred Resource to Indicated status with the completion of hole HMO-012 at 253.80m, being the 5th hole of the resource upgrade campaign. The results for hole HMO-010 are now available and the Company has advised the market that multiple high-grade zinc and germanium lodes have been confirmed by precise geo-chemical analysis. Mineralised intervals included 0.1m @ 9.6% Zn, 29g/t Ag, 19g/t Ge and 5.8% Pb from 44.24m depth, and 1.2m @ 5.5% Zn and 18g/t Ag from 97.50m depth, including 0.30m @ 54 g/t Ge. The Company awaits assay results from two other holes.
Transense Technologies 65.50p £9.51m (TRT.L)
The provider of specialist sensing solutions and measurement systems reports Interims to December 2025. The core trading divisions, SAWsense and Translogik, continue to deliver revenue growth of 39% although this is below the previous market expectations set out in the Company's announcement on 30 January. Total revenue reduced by 8% to £2.26m, gross margins are 90% and the profit was slightly above break-even compared to £0.55m is due to the contractual reduction in Bridgestone sales. The Company was cash generative in the period and available cash was £1.33m compared to £1.14m. The execution of the Company's strategy to develop scale and resilience at SAWsense and Translogik is progressing.
TPXImpact Holdings 35.00p £32.36m (TPX.L)
The technology-enabled services Company focused on people-powered digital transformation confirms an £11m contract uplift as part of its ongoing strategic delivery partnership with His Majesty's Land Registry (HMLR). This partnership is a key component of HMLR's transition toward a digital-first organisation, combining TPXimpact's specialist technical expertise with HMLR's deep sector knowledge. Through this integrated delivery model, the partnership has successfully advanced several critical initiatives. The work is making a vital public service more efficient, more transparent, and ready for the future.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
Hybridan Chefs
research@hybridan.com
Status of this Note and Disclaimer
This document has been provided as a general market commentary and is issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as investment advice; a recommendation; an offer to sell; nor solicitation of any offer to buy any security or other financial instrument. Nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. The information has been provided without taking into account the investment objective, financial situation or needs of any particular person. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
As market commentary, this document is not investment research or a research recommendation for regulatory purposes as it does not constitute substantive research or analysis. It is not subject to any prohibition on dealing ahead of the dissemination of investment research although Hybridan LLP maintains related internal systems and controls in connection with such dealing.
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result, both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
This document is not intended to be an invitation or inducement to engage in investment activity. In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are categorised by Hybridan LLP as either a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the avoidance of doubt, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. The information may contain projections or other forward-looking statements regarding future events, targets or expectations. There is no assurance that such events or expectations will be achieved, and actual results may be significantly different from that shown here. The information is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein.
References to specific securities, asset classes and financial markets are for illustrative purposes only. Past performance is no guarantee of future results. Information and opinions presented have been obtained or derived from sources which Hybridan LLP reasonably believed to be reliable however no representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any losses arising in any way from use of all or any part of the information in this document including, for the avoidance of doubt, direct or indirect or consequential loss or damage (including lost profits).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication.
In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Unless otherwise stated, Hybridan LLP owns the intellectual property rights and any other rights in this document. This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.